BDBM50525939 Balversa::Erdafitinib::Jnj-42756493

SMILES COc1cc(OC)cc(c1)N(CCNC(C)C)c1ccc2ncc(nc2c1)-c1cnn(C)c1

InChI Key InChIKey=OLAHOMJCDNXHFI-UHFFFAOYSA-N

Data  42 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 42 hits for monomerid = 50525939   

TargetFibroblast growth factor receptor 3(Human)
Astex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 3nMAssay Description:Inhibition of FGFR3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/21/2024
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 3nMAssay Description:Inhibition of FGFR3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 2(Human)
Celon Pharma

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of FGFR2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 2(Human)
Celon Pharma

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 1.5nMAssay Description:Inhibition of FGFR2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 0.420nMAssay Description:Inhibition of FGFR3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 4(Human)
Sichuan University

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 2nMAssay Description:Inhibition of FGFR4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 1(Human)
Nanjing University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 10nMAssay Description:Inhibition of FGFR1 (unknown origin) using FLT3 as substrate incubated for 60 mins in presence of ATP by time-resolved fluorescence energy-transfer a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/25/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 2(Human)
Celon Pharma

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 10nMAssay Description:Inhibition of FGFR2 (unknown origin) using FLT3 as substrate incubated for 30 mins in presence of ATP by time-resolved fluorescence energy-transfer a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/25/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 10nMAssay Description:Inhibition of FGFR3 (unknown origin) using FLT3 as substrate incubated for 60 mins in presence of ATP by time-resolved fluorescence energy-transfer a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/25/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 4(Human)
Sichuan University

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 10nMAssay Description:Inhibition of FGFR4 (unknown origin) using FLT3 as substrate incubated for 45 mins in presence of ATP by time-resolved fluorescence energy-transfer a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/25/2023
Entry Details
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Nanjing University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 10nMAssay Description:Inhibition of VEGFR2 (unknown origin) using FLT3 as substrate incubated for 60 mins in presence of ATP by time-resolved fluorescence energy-transfer ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/25/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 1(Human)
Nanjing University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 1(Human)
Nanjing University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 0.25nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetFibroblast growth factor receptor 2(Human)
Celon Pharma

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 1.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 0.420nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetFibroblast growth factor receptor 4(Human)
Sichuan University

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetFibroblast growth factor receptor 2(Human)
Celon Pharma

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 2.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetFibroblast growth factor receptor 1(Human)
Nanjing University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 1.20nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetFibroblast growth factor receptor 4(Human)
Sichuan University

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 5.70nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetPlatelet-derived growth factor receptor alpha/beta(Mouse)
Tyra Biosciences, Inc.

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 627nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetFibroblast growth factor receptor 4(Human)
Sichuan University

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 5.70nMAssay Description:Inhibition of FGFR4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 4(Human)
Sichuan University

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 5.70nMAssay Description:Inhibition of human FGFR4 incubated for 45 mins by time-resolved fluorescence kinase assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 2(Human)
Celon Pharma

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of human FGFR2 incubated for 30 mins by time-resolved fluorescence kinase assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Nanjing University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 37nMAssay Description:Inhibition of VEGFR2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 3nMAssay Description:Inhibition of N-terminal His6-tagged recombinant human FGFR3 (447 to 761 residues) incubated for 60 mins by time-resolved fluorescence kinase assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 3nMAssay Description:Inhibition of human recombinant N-terminal His6 tagged FGFR3 (447 to 761 residues) expressed in Sf21 cells using FLT3 peptide as substrate preincubat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details Article
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Nanjing University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 37nMAssay Description:Inhibition of human N-terminal His6-tagged VEGFR2 (790 to end residues) expressed in baculovirus infected Sf21 cells using FLT3 peptide as substrate ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2021
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 4(Human)
Sichuan University

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 3.80nMAssay Description:Inhibition of recombinant non-phosphorylated FGFR4 kinase domain (442 to 753) (unknown origin) expressed in Sf9 insect cells using 5-Fluo-Ahx-KKKKEEI...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 1(Human)
Nanjing University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of FGFR1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 2(Human)
Celon Pharma

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of FGFR2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 3nMAssay Description:Inhibition of FGFR3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 1(Human)
Nanjing University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of N-terminal GST-tagged recombinant human FGFR1 (456 to 765 amino acids) incubated for 60 mins by time-resolved fluorescence kinase assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetFibroblast growth factor receptor 1(Human)
Nanjing University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 1.5nMAssay Description:Inhibition of wild-type FGFR1 (unknown origin) by radiometric kinase activity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 2(Human)
Celon Pharma

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 0.5nMAssay Description:Inhibition of wild-type FGFR2 (unknown origin) by radiometric kinase activity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of wild-type FGFR3 (unknown origin) by radiometric kinase activity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 4(Human)
Sichuan University

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 19nMAssay Description:Inhibition of wild-type FGFR4 (unknown origin) by radiometric kinase activity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 1(Human)
Nanjing University of Chinese Medicine

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 1.66E+3nMAssay Description:Inhibition of FGFR1 V561M mutant (unknown origin) by radiometric kinase activity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 113nMAssay Description:Inhibition of FGFR3 V555M mutant (unknown origin) by radiometric kinase activity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 2(Human)
Celon Pharma

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 5.30nMAssay Description:Inhibition of FGFR2 N549H mutant (unknown origin) by radiometric kinase activity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 3(Human)
Astex Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of FGFR3 K650E mutant (unknown origin) by radiometric kinase activity assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2023
Entry Details
PubMed
TargetFibroblast growth factor receptor 4(Human)
Sichuan University

Curated by ChEMBL
LigandPNGBDBM50525939(Balversa | Erdafitinib | Jnj-42756493)
Affinity DataIC50: 5.70nMAssay Description:Inhibition of FGFR4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/18/2023
Entry Details
PubMed